Skip to content
Nanopharm-logo-with-signature-Pantone (1)
  • Home
  • SmartTrack™
  • About Us

    About Us

    Leadership Team

    Our Scientists

    Locations

  • Services

    Product Development

    Preformulation & Preclinical

    Spray Drying & Particle Engineering

    Formulation & Drug Product Development

    Clinical Development

    Clinical Trial Manufacturing

    cGMP Release & Stability Testing

    Clinical Labeling

    Analytical Services

    Research & Development

    Spray Characterization

    Method Development
    cGMP Release & Stability

    IVBE & CMC Studies

    Alternative Bioequivalence

    In-Silico Modeling

    PBPK Modeling Regional Deposition Modeling

    Regulatory

    Consultancy

    Alternative Bioequivalence
  • OINDP Expertise

    Nasal

    Nasal Powders

    Nasal Sprays

    Nasal Cast Deposition

    Inhalation

    DPI

    pMDI

    Low GWP Propellant pMDI

    Nebulizers

    Inhaled Biologics

    Generics & Lifecycle Management

    Reformulation & Repositioning

    IVBE

    Alternative Bioequivalence
  • Resources

    Resources

    Scientific Publications

    White Papers

    Posters
  • News & Events
  • Contact Us
  • Careers

Balancing Creativity with Compliance: Meet Kirsten Searle, Manager of Pharma Development

Discover how Kirsten Searle is enhancing project management excellence at Nanopharm. Hear about her philosophy on balancing pragmatic process with scientific innovation in a fast-paced CRO environment.

From ‘Quality Police’ to Lighthouse Leadership: Transforming QA in Pharma | Nanopharm

Justine Norman highlights Nanopharm’s shift from ‘Quality Police’ to lighthouse leadership in risk-based, innovative pharma QA

Discover how Nanopharm is redefining Quality Assurance as a strategic enabler in drug development. Learn how risk-based QA, innovation, and digital tools are improving outcomes for inhaled and nasal therapies.

Nanopharm logo

Transforming bioequivalence for orally inhaled and nasal drug products through advanced in vitro and in silico modeling.

Platform

  • OINDP Expertise
  • About Us
  • Services

Resources

  • Scientific Publications
  • White Papers
  • Posters
  • News Events

Contact

Nanopharm Ltd
Franklin House, Grange Road, Cwmbran, NP44 3WY, United Kingdom

info@nanopharm.co.uk
+44 (0) 1633 372200

© 2026 Nanopharm Ltd, an Aptar Pharma Company. All rights reserved.

Privacy PolicyTerms of Service